What is MED-LOGICS?
MED-LOGICS, Inc. operates at the intersection of advanced engineering and clinical ophthalmology. The company specializes in the development and distribution of high-quality products essential for cataract and LASIK surgeries, alongside a portfolio of donor cornea tissue products. Their flagship offerings, such as the ML7 microkeratome and the CataPulse lens removal system, are engineered to meet the rigorous demands of modern surgical environments. Beyond hardware, the company distinguishes itself through comprehensive support and repair services for microkeratome systems, ensuring that medical facilities maintain peak operational efficiency. By providing both the instrumentation and the technical maintenance required for sight-restoring procedures, MED-LOGICS serves as a critical partner to ophthalmic surgeons and specialized medical centers.
How much funding has MED-LOGICS raised?
MED-LOGICS has raised a total of $353K across 2 funding rounds:
Debt
$150K
Debt
$203K
Debt (2020): $150K with participation from PPP
Debt (2021): $203K led by PPP
Key Investors in MED-LOGICS
PPP
Public-Private Partnership
What's next for MED-LOGICS?
With the recent influx of capital, MED-LOGICS is poised to accelerate its research and development initiatives, focusing on the next generation of surgical precision tools. The strategic deployment of these funds will likely target the expansion of their product distribution networks and the enhancement of their service infrastructure. As the demand for minimally invasive ophthalmic procedures continues to rise, the company is strategically positioned to capture additional market share by leveraging its established reputation for reliability and technical excellence. Future growth will likely be driven by the integration of advanced materials and digital diagnostics into their existing surgical platforms, ensuring that MED-LOGICS remains at the forefront of the ophthalmic medical device industry.
See full MED-LOGICS company page
